Evidence method
Level · gp.fundamentals.debt_to_revenue
0.00% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
UTMD · Dec 31, 2021
UTAH MEDICAL PRODUCTS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001811884-22-000004General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
1.13% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
43.22% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
16.30% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
13.45% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
63.03% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
38.49% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.07% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
0.34% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History29 statesSelf-history eligible
Dec 31, 20217/9 normalizedLevel 3Mar 31, 20227/8 normalizedLevel 3Jun 30, 20227/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/9 normalizedLevel 3Dec 31, 20228/9 normalizedAmended as filedMar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/9 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/9 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/9 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 0.61%
- Current
- 1.13%
- Delta
- 0.51%
- Previous
- 47.65%
- Current
- 43.22%
- Delta
- -4.43%
- Previous
- 19.97%
- Current
- 16.30%
- Delta
- -3.67%
- Previous
- 50.10%
- Current
- 13.45%
- Delta
- -36.66%
- Previous
- 64.21%
- Current
- 63.03%
- Delta
- -1.19%
- Previous
- 40.55%
- Current
- 38.49%
- Delta
- -2.06%
- Previous
- 1.01%
- Current
- 1.07%
- Delta
- 0.06%
- Previous
- 0.33%
- Current
- 0.34%
- Delta
- 0.01%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · UTMD Fundamental State →Has State · UTAH MEDICAL PRODUCTS INC →Transitioned To · UTMD Fundamental State →Transitioned To · UTMD CAPEX_INTENSITY_INCREASED →Transitioned To · UTMD CASH_GENERATION_DECREASED →Transitioned To · UTMD GROWTH_DECREASED →Transitioned To · UTMD INVENTORY_PRESSURE_DECREASED →Transitioned To · UTMD MARGIN_DECREASED →Transitioned To · UTMD PROFITABILITY_DECREASED →Transitioned To · UTMD R_AND_D_INTENSITY_INCREASED →Transitioned To · UTMD SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.